Видео

Interested in learning how coronary inflammation drives coronary artery disease? Watch this Caristo Diagnostics sponsored symposium from @American_Heart 2024 annual meeting. Excellent presentations on coronary inflammation biomarkers and opportunities in prevention and treatment, by Prof Paul Ridker, (Brigham and Women’s Hospital, Boston) and Prof. Charalambos Antoniades (University of Oxford)....

This 45 second brand video spotlights our cutting-edge CaRi-Heart technology that prevents and predicts Heart Attack risk with more precision.

Watch our sponsored symposium at( @EuropeanSocietyofCardiology ) ESC Congress 2024, chaired by Prof. Peter Libby, Brigham and Women's Hospital and Harvard Medical School, and Prof. John Deanfield CBE, University College London. Excellent presentations from Prof. Ron Blankstein (Brigham and Women's Hospital and Harvard Medical School) and Prof. Charalambos Antoniades (University of Oxford) on th...

CaRi-Heart technology was featured on BBC News, both on TV and online on August 5, 2024. This in-depth story discusses how CaRi-Heart predicts heart attack risk by detecting coronary inflammation. BBC interviewed a patient who received care at one of the five NHS trusts currently piloting CaRi-Heart technology.

Prof. Keith Channon, Co-founder and Chief Medical Officer, Caristo, at SCCT in Budapest. Prof Channon presented the latest developments on CaRi-Heart® technology and shared findings from the ORFAN study, demonstrating the potential for Fat Attenuation Index Score to transform risk stratification and management of patients with coronary artery disease. Learn more about CaRi-Heart technology on o...

CaRi-Heart® Technology is a first-of-its-kind AI solution to measure coronary inflammation and characterize plaque on routine CCTA, helping clinicians diagnose and manage patients at risk of coronary artery disease. Watch the video to learn about how the technology works. The CaRi-Heart® platform is a cloud-based (SaaS) medical device, providing: *Seamless workflow *Secure and anonymized data t...

NBC affiliate WFLA-TV, interviewed Professor Keith Channon, Head of the Radcliffe Department of Medicine at Oxford University and Co-founder & Chief Medical Officer of Caristo Diagnostics, on the results from the ORFAN study announced at American Heart Association's annual meeting.

On World Heart Day, we are excited to share that British Heart Foundation has featured our Cari-Heart® technology as one of the innovations aimed at offering renewed hope to people with heart and circulatory diseases. In the UK today, there are at least 7.6 million people living with heart and circulatory diseases - but the true number is much higher. Many people living with these conditions do...

Watch this video to view our symposium at SCCT 2023 in Boston. Speakers: Peter Libby, MD; Ronak Rajani, MD, PhD, FSCCT; Brittany Weber, MD Discussion topics include: 0:00 -14:24 - The role of inflammation in Coronary Artery Disease 15:02 - 29:17 Science behind Fat Attenuation Index (FAI), a novel measurement of coronary inflammatory . Visualising coronary inflammation in CCTA 29:46 - 41:33 Clin...

@LaProvence-com (La Provence), a leading publication from France featured our CaRi-Heart® technology offered by Dr Tavildari at the Axium Clinic in France. Watch this video to learn how the CaRi-Heart® Analysis is helping Dr Tavildari in clinical practice. Our soltuion applies Artificial Intelligence to standard CCTA images to help diagnose Coronary Artery Disease and help physicians personalis...

The CaRi-Heart® Analysis is an AI-enabled imaging solution that quantifies coronary Inflammation and characterizes plaque, to help clinicians make more informed patient management decisions. This patented technology from Caristo is a cloud-based (SaaS) medical device that applies Artificial Intelligence to standard CCTA images. It uses a novel imaging biomarker, the Fat Attenuation Index (FAI) ...

Watch this video featuring Dr Martin Laser, Cardiologist, Parcside Clinic Germany, who uses CaRi-Heart® Analysis to understand his patient's cardiovascular disease activity. See how the analysis helped him prescribe a more personalised treatment for his patient, Christian from Nuremberg. The CaRi-Heart® Analysis is an AI-enabled imaging solution that quantifies coronary Inflammation and charact...

Watch this video to learn how Dr Nik Sabharwal, Consultant Cardiologist, Nuffield Health, Oxford used information from CaRi-Heart® analysis to personalise a treatment for his patient at-risk of cardiovascular disease.

Watch this video featuring Dr Tavildari, Cardiologist, Axium Clinic, who uses CaRi-Heart® Analysis to understand his patient's cardiovascular risk levels and disease activity. See how the analysis helped him prescribe a more personalised treatment for his patient

The future of comprehensive cardiovascular risk prediction using CCTA | SCCT Edinburgh 2023

CaRi-Heart® Analysis Patient Story - René | Predicted risk of heart attack

Heart Attack Prediction | Artificial Intelligence applied to Cardiac CT Scan | Coronary Inflammation